Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean M Wingerchuk

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Current Treatment Options in Neurology|March 8, 2008
Neuromyelitis opticaDean M Wingerchuk, Brian G Weinshenker
Seminars in Neurology|August 19, 2007
The MERITs of evidence-based clinical practice in neurologyBart M Demaerschalk, Dean M Wingerchuk
Neurology|April 24, 2002
Randomized controlled trials to assess therapies for multiple sclerosisDean M Wingerchuk, John H Noseworthy
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: YesEdgar Carnero Contentti, Dean M Wingerchuk
The New England Journal of Medicine|September 7, 2022
Neuromyelitis Optica Spectrum DisorderDean M Wingerchuk, Claudia F Lucchinetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both importantDean M Wingerchuk, Brian G Weinshenker
Multiple Sclerosis and Related Disorders|May 17, 2020
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19Cristina Valencia-Sanchez, Dean M Wingerchuk
The Neurologist|January 12, 2007
Critically appraised topics: the evidence-based neurologistDean M Wingerchuk, Bart M Demaerschalk
The New England Journal of Medicine|September 8, 2010
Clinical practice. Transverse myelitisElliot M Frohman, Dean M Wingerchuk
Mayo Clinic Proceedings|February 4, 2014
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategiesDean M Wingerchuk, Jonathan L Carter
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Current Treatment Options in Neurology|March 8, 2008
Neuromyelitis opticaDean M Wingerchuk, Brian G Weinshenker
Seminars in Neurology|August 19, 2007
The MERITs of evidence-based clinical practice in neurologyBart M Demaerschalk, Dean M Wingerchuk
Neurology|April 24, 2002
Randomized controlled trials to assess therapies for multiple sclerosisDean M Wingerchuk, John H Noseworthy
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2024
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: YesEdgar Carnero Contentti, Dean M Wingerchuk
The New England Journal of Medicine|September 7, 2022
Neuromyelitis Optica Spectrum DisorderDean M Wingerchuk, Claudia F Lucchinetti
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both importantDean M Wingerchuk, Brian G Weinshenker
Multiple Sclerosis and Related Disorders|May 17, 2020
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19Cristina Valencia-Sanchez, Dean M Wingerchuk
The Neurologist|January 12, 2007
Critically appraised topics: the evidence-based neurologistDean M Wingerchuk, Bart M Demaerschalk
The New England Journal of Medicine|September 8, 2010
Clinical practice. Transverse myelitisElliot M Frohman, Dean M Wingerchuk
Mayo Clinic Proceedings|February 4, 2014
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategiesDean M Wingerchuk, Jonathan L Carter
Pageof 19